Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial
The aim of this study was to explore the efficacy and safety of obinutuzumab (G)- versus rituximab (R)-chemotherapy in a subgroup of patients with previously untreated marginal zone lymphoma (MZL) in the phase III GALLIUM trial (NCT01332968). Patients had stage III/IV (or stage II with bulky disease...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wiley
2022-03-01
|
| 叢編: | HemaSphere |
| 在線閱讀: | http://journals.lww.com/10.1097/HS9.0000000000000699 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|